Puerto Rico Opens Research and Development Center for Pharmaceutical Products - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Puerto Rico Opens Research and Development Center for Pharmaceutical Products



The Puerto Rico Industrial Development Company and governor Alejandro García Padilla had an inauguration ceremony for Neolpharma's new Development and Innovation Center (CEDIPROF) for pharmaceutical products in Puerto Rico.

In 2013, Neolpharma invested over $12 million in machinery and equipment in the center in Puerto Rico. The center will create 23 new jobs. CEDIPROF includes a 2000 ft2 pilot facility for research, development, and evaluation of new pharmaceutical products, as well as an analytic and forensic laboratory and a 4000 ft2 warehouse.

Source: Puerto Rico Industrial Development Company

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here